Alcohol consumption in Europe - What is needed for effective harm reduction?
05-12-2024
Noncommunicable diseases (NCDs) such as liver disease, cardiovascular diseases, diabetes, chronic respiratory diseases, mental disorders, neurological disorders, and cancer are responsible for 80% of the disease burden in EU countries. They are the leading causes of avoidable premature deaths. The significant human and financial costs of NCDs are expected to rise due to an ageing EU population (European Commission).
Alcohol consumption is a major contributor to many NCDs, and Europe stands as the world’s highest alcohol-consuming region. According to the World Health Organization, liver disease, largely driven by alcohol consumption, is now the second leading cause of years of working life lost in Europe. Moreover, around 300,000 people in Europe die prematurely each year due to liver problems. There is a direct correlation between overall alcohol consumption
and liver mortality in 21 of 28 European Union (EU) Member States. Maintaining liver health is also essential for preventing raised cholesterol.
Although the European Commission supports EU countries in identifying and implementing effective policies and actions to reduce the burden of major NCDs, there are few alcohol-specific policies at the EU level.
Ongoing initiatives at the EU level, such as the EU’s Beating Cancer Plan and actions by the European Commission, including labelling ingredients and nutritional information and health warning labels on alcoholic beverages, are seen as opportunities to address the overall burden of alcohol-related diseases.
Join this Euractiv Stakeholder Workshop to discuss policy measures related to reducing and preventing alcohol-related harms. Some questions to be addressed include:
- What does a focus on health promotion and disease prevention
concerning alcohol entail? What are the policy gaps in this area?
- What alcohol policy proposals could be effective and integrated into current health policy?
- How can EU policies better address alcohol-related liver disease to reduce premature deaths?
- Do current policies prioritise commercial interests over population health? How could this be addressed?
- Can we better address deprived populations who suffer most from alcoholrelated harms?
Please note that this event is in-person only and will not be live-streamed.
Supported by:
Location
Euractiv Network Office
Boulevard Charlemagne 1, 1041 Brussels
Google Maps >>
Panellists
Marta Temido MEP
ENVI & SANT Committees, European Parliament
Tomislav Sokol MEP
ENVI and SANT Committees, European Parliament
Catherine Paradis
Technical Officer, Alcohol, Illicit Drugs and Prison Health Unit, WHO Regional Office for Europe
Dr Samuele Tonello
Senior Research Coordinator, EuroHealthNet
Florence Berteletti
Secretary General, Eurocare
Prof. Frank Murray
Policy, Public Health and Advocacy Committee Member, EASL
Moderator
Mariam Zaidi
Euractiv
Schedule
16:30 - 17:00 Registration
17:00 - 17:05 Welcome
17:05 - 17:20 Panellist statements
17:20 - 18:10 Discussion and Q&A
18:10 - 18:15 Closing statements
Followed by a light networking reception
Contact
Síofra Gilmore
siofra.gilmore@euractiv.com